Circadian rhythm of blood pressure in congestive heart failure and effects of ACE inhibitors.
暂无分享,去创建一个
[1] O. Hess,et al. [Comparison of enalapril and captopril in the treatment of chronic heart failure]. , 1990, Zeitschrift fur Kardiologie.
[2] A. Malliani,et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. , 1990, Circulation.
[3] G. Schillaci,et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. , 1990, Circulation.
[4] M. Packer,et al. Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition. , 1987, European heart journal.
[5] G. Parati,et al. Balanced 24-hour blood pressure control by angiotensin-converting enzyme inhibitors administered once daily. , 1989, Journal of human hypertension.
[6] J. Rouleau,et al. Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure , 1989 .
[7] M. Jessup. Angiotensin-converting enzyme inhibitors: are there significant clinical differences? , 1989, Journal of the American College of Cardiology.
[8] G. Francis,et al. Long-term effects of a once-a-day versus twice-a-day regimen of enalapril for congestive heart failure. , 1989, The American journal of cardiology.
[9] M. Weber. Automated blood pressure monitoring: a new dimension in diagnosis. , 1988, Mayo Clinic proceedings.
[10] M. Weber,et al. Validation of portable noninvasive blood pressure monitoring devices: comparisons with intra-arterial and sphygmomanometer measurements. , 1988, American heart journal.
[11] D. Altman,et al. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. , 1988, The American journal of cardiology.
[12] G. Parati,et al. Experience with 24-hour ambulatory blood pressure monitoring in hypertension. , 1988, American heart journal.
[13] D. Ganten,et al. Endogenous tissue renin-angiotensin systems. From molecular biology to therapy. , 1988, The American journal of medicine.
[14] M. Weber. Whole-day blood pressure. , 1988, Hypertension.
[15] M. Wilén,et al. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. , 1988, JAMA.
[16] M. Packer,et al. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. , 1987, Annals of internal medicine.
[17] M. Packer,et al. Comparison of captopril and enalapril in patients with severe chronic heart failure. , 1986, The New England journal of medicine.
[18] M. Packer,et al. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. , 1986, Circulation.
[19] A. Mark,et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.
[20] P. Korner,et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.
[21] R. Heel,et al. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. , 1986, Drugs.
[22] T. Ryan,et al. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. , 1985, Journal of the American College of Cardiology.
[23] J. Drayer,et al. Automated ambulatory blood pressure monitoring: a study in age-matched normotensive and hypertensive men. , 1985, American heart journal.
[24] B. W. East,et al. Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.
[25] M. Pfeffer,et al. Role of Angiotensin II in the Altered Renal Function of Congestive Heart Failure , 1984, Circulation research.
[26] T. Unger,et al. Is Tissue Converting Enzyme Inhibition a Determinant of the Antihypertensive Efficacy of Converting Enzyme Inhibitors? Studies with the Two Different Compounds, Hoe498 and MK421, in Spontaneously Hypertensive Rats , 1984, Journal of cardiovascular pharmacology.
[27] D. Sharpe,et al. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. , 1984, Circulation.
[28] J. Drayer,et al. The circadian blood pressure pattern in ambulatory normal subjects. , 1984, The American journal of cardiology.
[29] B. Massie,et al. Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study , 1983, Circulation.
[30] D L Eckberg,et al. Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.